Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,854Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Aricept

02 1Namzaric

PharmaCompass

01

Brand Name : Namzaric

arrow
2024 ACI Convention
Not Confirmed

Donepezil Hydrochloride

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 89

2018 Revenue in Millions : 116

Growth (%) : -23

Abbvie CB

02

Brand Name : Aricept

Donepezil

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aricept

arrow
2024 ACI Convention
Not Confirmed

Donepezil

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 255

2019 Revenue in Millions : 340

Growth (%) : -25

blank

03

Brand Name : Aricept

Donepezil

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aricept

arrow
2024 ACI Convention
Not Confirmed

Donepezil

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 208

2020 Revenue in Millions : 245

Growth (%) : -9

blank

04

Brand Name : Aricept

Donepezil

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aricept

arrow
2024 ACI Convention
Not Confirmed

Donepezil

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 187

2021 Revenue in Millions : 208

Growth (%) : -10.1

blank

05

Brand Name : Aricept

Donepezil

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aricept

arrow
2024 ACI Convention
Not Confirmed

Donepezil

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 156

2022 Revenue in Millions : 184

Growth (%) : -5

blank

06

Brand Name : Aricept

Donepezil Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aricept

arrow
2024 ACI Convention
Not Confirmed

Donepezil Hydrochloride

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 429

2016 Revenue in Millions : 448

Growth (%) : -4

blank

07

Brand Name : Aricept

Donepezil Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aricept

arrow
2024 ACI Convention
Not Confirmed

Donepezil Hydrochloride

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 357

2017 Revenue in Millions : 402

Growth (%) : -11%

blank

08

Brand Name : Aricept

Donepezil

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aricept

arrow
2024 ACI Convention
Not Confirmed

Donepezil

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 333

2018 Revenue in Millions : 369

Growth (%) : -10

blank